149 related articles for article (PubMed ID: 26841328)
21. Tall cell variant of papillary thyroid carcinoma: current evidence on clinicopathologic features and molecular biology.
Wang X; Cheng W; Liu C; Li J
Oncotarget; 2016 Jun; 7(26):40792-40799. PubMed ID: 27008708
[TBL] [Abstract][Full Text] [Related]
22. Reevaluating the prognostic significance of male gender for papillary thyroid carcinoma and microcarcinoma: a SEER database analysis.
Liu C; Chen T; Zeng W; Wang S; Xiong Y; Liu Z; Huang T
Sci Rep; 2017 Sep; 7(1):11412. PubMed ID: 28900207
[TBL] [Abstract][Full Text] [Related]
23. CHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinoma.
Luo D; Chen H; Lu P; Li X; Long M; Peng X; Huang M; Huang K; Lin S; Tan L; Zhu Y; Chen Z; Ouyang N; Li H
Cancer Biomark; 2017; 18(3):273-284. PubMed ID: 28009325
[TBL] [Abstract][Full Text] [Related]
24. Pediatric patients with multifocal papillary thyroid cancer have higher recurrence rates than adult patients: a retrospective analysis of a large pediatric thyroid cancer cohort over 33 years.
Lee YA; Jung HW; Kim HY; Choi H; Kim HY; Hah JH; Park DJ; Chung JK; Yang SW; Shin CH; Park YJ
J Clin Endocrinol Metab; 2015 Apr; 100(4):1619-29. PubMed ID: 25632969
[TBL] [Abstract][Full Text] [Related]
25. The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.
Lin KL; Wang OC; Zhang XH; Dai XX; Hu XQ; Qu JM
Ann Surg Oncol; 2010 Dec; 17(12):3294-300. PubMed ID: 20953721
[TBL] [Abstract][Full Text] [Related]
26. The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients.
Lubitz CC; Sosa JA
Cancer; 2016 Dec; 122(24):3754-3759. PubMed ID: 27517675
[TBL] [Abstract][Full Text] [Related]
27. A comparison of the clinicopathological features and prognoses of the classical and the tall cell variant of papillary thyroid cancer: a meta-analysis.
Liu Z; Zeng W; Chen T; Guo Y; Zhang C; Liu C; Huang T
Oncotarget; 2017 Jan; 8(4):6222-6232. PubMed ID: 28009980
[TBL] [Abstract][Full Text] [Related]
28. Stomatin-like protein 2 overexpression in papillary thyroid carcinoma is significantly associated with high-risk clinicopathological parameters and BRAFV600E mutation.
Bartolome A; Boskovic S; Paunovic I; Bozic V; Cvejic D
APMIS; 2016 Apr; 124(4):271-7. PubMed ID: 26750533
[TBL] [Abstract][Full Text] [Related]
29. TERT promoter mutations are associated with distant metastases in papillary thyroid carcinoma.
Gandolfi G; Ragazzi M; Frasoldati A; Piana S; Ciarrocchi A; Sancisi V
Eur J Endocrinol; 2015 Apr; 172(4):403-13. PubMed ID: 25583906
[TBL] [Abstract][Full Text] [Related]
30. [Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].
Qian K; Sun TQ; Guo K; Zheng XK; Li DS; Wei WW; Wu Y; Ji QH; Wang ZY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 52(6):430-434. PubMed ID: 28635215
[No Abstract] [Full Text] [Related]
31. Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients.
Vasileiadis I; Karakostas E; Charitoudis G; Stavrianaki A; Kapetanakis S; Kouraklis G; Karatzas T
Eur J Clin Invest; 2012 Jun; 42(6):657-64. PubMed ID: 22168782
[TBL] [Abstract][Full Text] [Related]
32. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
[TBL] [Abstract][Full Text] [Related]
33. Incidental and nonincidental papillary thyroid microcarcinoma.
Lin JD; Kuo SF; Chao TC; Hsueh C
Ann Surg Oncol; 2008 Aug; 15(8):2287-92. PubMed ID: 18483830
[TBL] [Abstract][Full Text] [Related]
34. Lack of Efficacy of Radioiodine Remnant Ablation for Papillary Thyroid Microcarcinoma: Verification Using Inverse Probability of Treatment Weighting.
Kwon H; Jeon MJ; Kim WG; Park S; Kim M; Kim TY; Han M; Song DE; Sung TY; Yoon JH; Hong SJ; Ryu JS; Shong YK; Kim WB
Ann Surg Oncol; 2017 Sep; 24(9):2596-2602. PubMed ID: 28600731
[TBL] [Abstract][Full Text] [Related]
35. Well-differentiated thyroid cancer with a minor poorly differentiated component: clonal heterogeneity through the prognostic role of CXCR4 and BRAF analysis.
Rossi ED; Martini M; Capodimonti S; Straccia P; Revelli L; Lombardi CP; Pontecorvi A; Santeusanio G; Larocca LM; Fadda G
Appl Immunohistochem Mol Morphol; 2015 Mar; 23(3):196-201. PubMed ID: 24992171
[TBL] [Abstract][Full Text] [Related]
36. Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma.
Kwak JY; Kim EK; Chung WY; Moon HJ; Kim MJ; Choi JR
Radiology; 2009 Dec; 253(3):854-60. PubMed ID: 19710001
[TBL] [Abstract][Full Text] [Related]
37. The BRAF(V600E) mutation in papillary thyroid microcarcinoma: does the mutation have an impact on clinical outcome?
Walczyk A; Kowalska A; Kowalik A; Sygut J; Wypiórkiewicz E; Chodurska R; Pięciak L; Góźdź S
Clin Endocrinol (Oxf); 2014 Jun; 80(6):899-904. PubMed ID: 24354346
[TBL] [Abstract][Full Text] [Related]
38. Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data.
Chai YJ; Yi JW; Jee HG; Kim YA; Kim JH; Xing M; Lee KE
PLoS One; 2016; 11(7):e0159235. PubMed ID: 27410688
[TBL] [Abstract][Full Text] [Related]
39. Multifocality predicts poor outcome of patients with insular thyroid cancer: a clinicopathological study.
Liu L; Li D; Wang H; Yang X; Yu Y; Gao M
Int J Clin Exp Pathol; 2015; 8(9):11212-7. PubMed ID: 26617844
[TBL] [Abstract][Full Text] [Related]
40. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
